KERIANN GIACOMAZZA: Open Payments
NPI 1366867913 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 29 payments from 8 companies in 2025. Trend: 2023 $695 · 2024 $434 · 2025 $499
Food & beverage: $399Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $164 |
| ABBVIE INC. | 14 | $151 |
| GENZYME CORPORATION | 3 | $54 |
| Incyte Corporation | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Lilly USA, LLC | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
| LEO Pharma Inc. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, NEMLUVIO, EBGLYSS, Cabtreo, ADBRY.
Industry payments across NY — which companies pay providers there.
